Representatives Ami Bera, M.D. (D-CA) and Mike Kelly (R-PA) today introduced the Data for Pediatric Brain Cancer Act of 2023, bipartisan legislation to strengthen the collection and use of real-world data to support pediatric cancer research, and to improve treatments for children facing this devastating disease.
“As a physician, I am proud to introduce the Data for Pediatric Brain… Read more »
Today, U.S. Representatives Ami Bera, M.D. (D-CA) and Larry Bucshon, M.D. (R-IN) responded to the final Physician Fee Schedule Rule, which reflects a 3.4% cut to the conversion factor used for calculating physician reimbursement. Congress passed the Medicare Access and CHIP Reauthorization Act (MACRA) with the intent of moving toward a system… Read more »
WASHINGTON, DC – Representative Ami Bera, M.D. (CA-06) today released the following statement after re-introducing the Affordable Rabies Treatment for All Act of 2023. Read more »
Link
Rep. Ami Bera (D-Calif.) isn't giving up on his push to turn his brush with a rabid Capitol fox in April 2022 into positive public policy change.
His bill, which he reintroduced after a first attempt last year, would create a reimbursement program for providers who treat uninsured individuals for rabies and enable grants for local health department to stockpile treatments for the… Read more »
WASHINGTON, DC – Representatives Ami Bera, M.D. (D-CA), Larry Bucshon, M.D. (R-IN), Kim Schrier (D-WA), Mariannette Miller-Meeks, M.D. (R-IA), Earl Blumenauer (D-OR), and Brad Schneider (D-IL) today led over 90 Members of Congress in a bipartisan letter to Speaker McCarthy and Leader Jeffries emphasizing the urgent need to establish a stable Medicare payment system that appropriately pays… Read more »
WASHINGTON, DC – Representative Ami Bera, M.D. (CA-06) today released the following statement after the House Foreign Affairs Committee voted unanimously to send his bipartisan bill, the End TB Now Act of 2023, to the floor of the U.S. House of Representatives for a full vote. Read more »
Today, Representative Ami Bera, M.D. (D-CA) released the following statement on the U.S. Food and Drug Administration (FDA) approving the first-ever over-the-counter birth control pill available in the United States.
“The FDA’s approval of the first-ever over-the-counter birth control pill marks a historic victory for women’s health care and reproductive rights,” said Rep. Ami Bera, who… Read more »
Representatives Ami Bera, M.D. (D-CA) and María Elvira Salazar (R-FL), co-chairs of the House Tuberculosis Elimination Caucus, and Chairman Michael McCaul (R-TX) and Ranking Member Gregory Meeks (D-NY) of the House Foreign Affairs Committee today led 104 colleagues in a bipartisan letter to the Biden Administration urging bold U.S. leadership at the upcoming United Nations High Level… Read more »
Today, Representatives Ami Bera, M.D. (CA-06), Suzan DelBene (WA-01), Mike Kelly (PA-16), and Larry Bucshon, M.D. (IN-08), and Senators John Thune (R-SD), Sherrod Brown (D-OH), Roger Marshall, M.D. (R-KS), and Kyrsten Sinema (AZ) called on the Centers for Medicare & Medicaid Services (CMS) to quickly finalize a set of proposed rules that would deliver quality care to seniors on… Read more »
Today, Representatives Ami Bera, M.D. (D-CA), Brian Fitzpatrick (R-PA), Derek Kilmer (D-WA), and Mike Kelly (R-PA) led 66 Members of Congress in a bipartisan letter to the U.S. Department of Health and Human Services Secretary Xavier Becerra and U.S. Food and Drug Administration Commissioner Robert Califf expressing concern with the detrimental impact of drug shortages on individuals… Read more »
